S21-063 TLR7-agonist-nanoparticle vaccine adjuvant Stanford researchers have developed a nanoparticle adjuvant with spatiotemporal controlled release of TLR7 agonist for broad protection against influenza or SARS-CoV-2. Qian Yin Mark Davis Wei Luo Bali Pulendran